Fda

FDA approves gene-targeting skin cancer drug

By MATTHEW PERRONE - Associated Press

LETTER TO THE EDITOR: Questionable motives behind supplement bill

The Washington Times

JOHNSON: Enough to make you lose your appetite

By Beth Johnson - The Washington Times

FDA takes new look at what “gluten free” means

By MARY CLARE JALONICK - Associated Press

APNewsBreak: FDA says sleepy brownies are unsafe

By MARY CLARE JALONICK - Associated Press

Experts say medical device review system “flawed”

By MATTHEW PERRONE - Associated Press

MINTON: The coming war on vitamins

By Michelle Minton - The Washington Times

Appeals court weighs tobacco companies’challenge to FDA rules

Associated Press

FDA plans to regulate some mobile phone apps

By ASSOCIATED PRESS - Associated Press

J&J wins US approval for new blood thinner

By MATTHEW PERRONE - Associated Press

Bill revision could mean money for NJ drug company

By JIM ABRAMS - Associated Press

FDA panel: Avastin not effective for breast cancer

By ASSOCIATED PRESS - Associated Press

FDA panel again nixes Avastin for breast cancer

By Matthew Perrone - Associated Press

FDA panel: Revoke drug’s breast cancer approval

By MATTHEW PERRONE - Associated Press

States consider banning teens from tanning beds

By SHAYA TAYEFE MOHAJER - Associated Press

FDA says 1 in 5 remove breast implants

By Matthew Perrone and Lauran Neergaard - The Washington Times

FDA concludes silicone breast implants mostly safe

By Matthew Perrone - Associated Press

FDA issues graphic cigarette labels

By Michael Felberbaum - Associated Press

Grim images must be put on cigarette packs by fall 2012

By Michael Felberbaum - Associated Press

WOLF: The FDA’s one-man death panel

By Dr. Milton R. Wolf

Glicked rocks theaters as ‘Wicked’ and ‘Gladiator II’ now available

AI Jesus installed in Swiss confessional booth

Speaker Johnson shuts the door on transgender women using Capitol’s female bathrooms

Latest Stories

FDA approves gene-targeting skin cancer drug

LETTER TO THE EDITOR: Questionable motives behind supplement bill

JOHNSON: Enough to make you lose your appetite

FDA takes new look at what “gluten free” means

APNewsBreak: FDA says sleepy brownies are unsafe

Experts say medical device review system “flawed”

MINTON: The coming war on vitamins

Appeals court weighs tobacco companies’challenge to FDA rules

FDA plans to regulate some mobile phone apps

J&J wins US approval for new blood thinner

Bill revision could mean money for NJ drug company

FDA panel: Avastin not effective for breast cancer

FDA panel again nixes Avastin for breast cancer

FDA panel: Revoke drug’s breast cancer approval

States consider banning teens from tanning beds

FDA says 1 in 5 remove breast implants

FDA concludes silicone breast implants mostly safe

FDA issues graphic cigarette labels

Grim images must be put on cigarette packs by fall 2012

WOLF: The FDA’s one-man death panel